A pilot study of the clinical efficacy and safety of memantine for Huntington's disease
Authors:
- William G. OndoWOWilliam G. Ondo
- Nicte I. MejiaNMNicte I. Mejia
- Christine B. HunterCHChristine B. Hunter
- 1 October 2007
- journal article
- other
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 13 (7) , 453-454
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegenerationFEBS Letters, 2004
- The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease2004
- Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatumNeuroscience Letters, 2003
- Huntington’s diseaseNeurology, 2002